8-K: Dentsply Sirona Reports First Quarter 2025 Results: Sales Decline, but Adjusted EBITDA Margin Expands

Dentsply Sirona's Q1 2025 results show a decrease in net sales but an expansion in adjusted EBITDA margin, with the company maintaining its FY25 outlook for organic sales and adjusted EPS.

Summary

• Dentsply Sirona announced its financial results for the first quarter of 2025.
• Net sales were $879 million, a decrease of 7.7% compared to Q1 2024.
• Organic sales decreased by 4.4%, including a 4.0% impact from Byte sales.
• GAAP gross margin was 53.0%, and GAAP net income was $20 million, or $0.10 per share.
• Adjusted gross margin was 56.3%, adjusted EBITDA margin was 19.0%, and adjusted EPS was $0.43.
• The company is maintaining its FY25 outlook for organic sales (down 4.0% to 2.0%) and adjusted EPS ($1.80 to $2.00).
• The company is increasing its expected reported sales to a new range of $3.60 billion to $3.70 billion due to changes in foreign exchange rates.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While sales declined, the company is maintaining its outlook and improving efficiency, suggesting a degree of resilience and proactive management.

Positives

• Adjusted EBITDA margin expanded to 19.0% from 16.8% in Q1 2024, reflecting benefits from transformational initiatives and financial discipline.
• Adjusted EPS increased to $0.43 from $0.42 in Q1 2024.
• The company is increasing its expected reported sales to a new range of $3.60 billion to $3.70 billion due to changes in foreign exchange rates.

Negatives

• Net sales decreased by 7.7% to $879 million in Q1 2025.
• Organic sales decreased by 4.4%, impacted by Byte sales.
• Operating cash flow decreased to $7 million from $25 million due to unfavorable timing of collections and inventory build.

Risks

• The company is operating in an increasingly uncertain macroeconomic environment.
• The company's forward-looking statements are subject to numerous assumptions, risks, and uncertainties.
• Foreign currency changes negatively impacted first quarter 2025 net sales by approximately ($30) million.

Future Outlook

The company is maintaining its 2025 outlook for organic sales in the range of down (4.0%) to (2.0%), and adjusted EPS in the range of $1.80 to $2.00. The company is increasing its expected reported sales to a new range of $3.60 billion to $3.70 billion due to changes in foreign exchange rates.

Management Comments

• 'In the first quarter, organic sales were roughly flat excluding the Byte sales impact, with growth in two of our three regions.'
• 'Adjusted EBITDA margin expanded which primarily reflects the benefits from our transformational initiatives and internal financial discipline.'
• 'We are delivering progress through customer-centric innovation, customer experience improvements, and operational efficiency, while operating in an increasingly uncertain macroeconomic environment,' said Simon Campion, President and Chief Executive Officer.
• 'Looking forward, we are maintaining our outlook for organic sales and adjusted EPS and will continue to focus on improving what is within our control to deliver sustainable long-term performance.'

Industry Context

Dentsply Sirona, as the world's largest diversified manufacturer of professional dental products and technologies, is facing challenges similar to others in the dental industry, including macroeconomic uncertainty and fluctuating foreign exchange rates. The company's focus on innovation and efficiency is a common strategy in the competitive dental market.

Comparison to Industry Standards

• Competitors like Envista and Straumann Group also operate in the dental products and technologies market.
• Dentsply Sirona's organic sales decline of 4.4% should be compared to the organic growth rates of its peers to assess relative performance.
• The adjusted EBITDA margin of 19.0% can be benchmarked against industry averages and the margins of competitors to evaluate profitability.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the sales decline but encouraged by the maintained outlook and improved efficiency.
• Employees may be affected by restructuring initiatives aimed at improving efficiency.
• Customers should benefit from the company's focus on customer-centric innovation and experience improvements.

Next Steps

• Dentsply Sirona's management team will host an investor conference call and live webcast on May 8th, 2025, at 8:30 am ET.

Key Dates

Keywords

Dentsply Sirona, financial results, first quarter 2025, net sales, organic sales, EBITDA, EPS, dental products